Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-10 Sale | 2022-11-14 9:00 pm | Zymeworks BC Inc. | ZYME | Josephson Neil Chief Medical Officer | 2,475 | $8.099 | $20,045 | 26,221 (Direct) | View |
| 2022-03-10 Sale | 2022-03-11 9:00 pm | Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer | 2,979 | $6.88 | $20,496 | 221,893 (Indirect Direct) | View |
| 2022-01-07 Purchase | 2022-01-11 9:47 pm | Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer | 5,000 | $14.28 | $71,386 | 7,119 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-11-10 Exercise | 2022-11-14 9:00 pm | N/A N/A | Zymeworks BC Inc. | ZYME | Josephson Neil Chief Medical Officer | 5,885 | $0 | 26,221 (Direct) | View |
| 2022-07-18 Option Award | 2022-07-19 9:05 pm | N/A 2032-07-17 | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-05 9:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer | 1,525 | $4.51 | 11,039 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-05 9:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer | 1,525 | $4.51 | 15,501 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-11 9:00 pm | N/A 2032-03-09 | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-11 9:00 pm | N/A 2032-03-09 | Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer | 200,000 | $0 | 221,893 (Direct) | View |
| 2022-03-10 Exercise | 2022-03-11 9:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer | 5,208 | $0 | 221,893 (Direct) | View |
| 2022-03-10 Exercise | 2022-03-11 9:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer | 2,395 | $0 | 13,578 (Direct) | View |
Ownership | 2022-03-04 9:20 pm | N/A N/A | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 0 | $0 | 21,020 (Direct) | View |
| 2022-01-15 Option Award | 2022-01-18 06:25 am | N/A 2032-01-14 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair, President & CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:30 pm | N/A N/A | Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer | 65 | $13.94 | 2,119 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:30 pm | N/A N/A | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 74 | $13.94 | 36,407 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:30 pm | N/A N/A | Zymeworks Inc. | ZYME | Klompas Neil A Chief Operating Officer & CFO | 277 | $13.94 | 11,747 (Direct) | View |
| 2021-11-10 Option Award | 2021-11-12 9:00 pm | N/A 2031-11-09 | Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer | 123,600 | $0 | 123,600 (Direct) | View |